| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |